Chuay-Yeng Koo

2.5k total citations · 1 hit paper
22 papers, 2.0k citations indexed

About

Chuay-Yeng Koo is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Chuay-Yeng Koo has authored 22 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Cell Biology and 4 papers in Oncology. Recurrent topics in Chuay-Yeng Koo's work include Proteoglycans and glycosaminoglycans research (6 papers), FOXO transcription factor regulation (5 papers) and Fibroblast Growth Factor Research (3 papers). Chuay-Yeng Koo is often cited by papers focused on Proteoglycans and glycosaminoglycans research (6 papers), FOXO transcription factor regulation (5 papers) and Fibroblast Growth Factor Research (3 papers). Chuay-Yeng Koo collaborates with scholars based in United Kingdom, Singapore and United States. Chuay-Yeng Koo's co-authors include Eric W.‐F. Lam, Ana Gomes, Jan J. Brosens, Kyle Muir, George W. Yip, Martin Götte, Sherif Ibrahim, Ludwig Kiesel, Lara J. Monteiro and Christian Stock and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Nature reviews. Cancer.

In The Last Decade

Chuay-Yeng Koo

21 papers receiving 2.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Forkhead box proteins: tuning forks for transcriptional harmony

2013 555 citations Eric W.‐F. Lam, Jan J. Brosens et al. Nature reviews. Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chuay-Yeng Koo United Kingdom	16	1.5k	496	368	368	187	22	2.0k
Yie Liu United States	31	1.8k 1.1×	218 0.4×	441 1.2×	164 0.4×	200 1.1×	62	2.5k
Isabel García‐Cao Spain	15	1.4k 0.9×	442 0.9×	726 2.0×	153 0.4×	80 0.4×	16	1.9k
Jennifer A. Calvo United States	15	1.7k 1.1×	326 0.7×	552 1.5×	178 0.5×	124 0.7×	25	2.3k
Paola Ostano Italy	25	1.2k 0.8×	552 1.1×	703 1.9×	201 0.5×	87 0.5×	59	2.1k
Harald Scheuch Austria	12	1.2k 0.8×	376 0.8×	601 1.6×	212 0.6×	124 0.7×	13	2.0k
Paul J. Coffer Netherlands	18	1.4k 0.9×	272 0.5×	353 1.0×	232 0.6×	156 0.8×	27	2.1k
Isabella Manni Italy	25	1.9k 1.2×	494 1.0×	785 2.1×	218 0.6×	84 0.4×	57	2.5k
Mickaël Ohanna France	21	1.4k 0.9×	282 0.6×	503 1.4×	518 1.4×	52 0.3×	27	2.1k
Abdelhadi Rebbaa United States	21	1.0k 0.7×	228 0.5×	293 0.8×	239 0.6×	57 0.3×	46	1.6k
Julien Fitamant United States	14	1.7k 1.1×	468 0.9×	648 1.8×	989 2.7×	90 0.5×	17	2.8k

Countries citing papers authored by Chuay-Yeng Koo

Since Specialization

Citations

This map shows the geographic impact of Chuay-Yeng Koo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chuay-Yeng Koo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chuay-Yeng Koo more than expected).

Fields of papers citing papers by Chuay-Yeng Koo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chuay-Yeng Koo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chuay-Yeng Koo. The network helps show where Chuay-Yeng Koo may publish in the future.

Co-authorship network of co-authors of Chuay-Yeng Koo

This figure shows the co-authorship network connecting the top 25 collaborators of Chuay-Yeng Koo. A scholar is included among the top collaborators of Chuay-Yeng Koo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chuay-Yeng Koo. Chuay-Yeng Koo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Koo, Chuay-Yeng, et al.. (2026). BCDX2–CX3 and DX2–CX3 complexes assemble and stabilize RAD51 filaments. Nature.

Guha, Avirup, Jehonathan H. Pinthus, R Piccoli, et al.. (2024). Educational attainment and cardiovascular outcomes in prostate cancer: observations from 3700 men in 6 countries in the RADICAL PC study. European Heart Journal. 45(Supplement_1). 1 indexed citations

Giacomini, Caterina, Chuay-Yeng Koo, Ignatius A. Tavares, et al.. (2018). A new TAO kinase inhibitor reduces tau phosphorylation at sites associated with neurodegeneration in human tauopathies. Acta Neuropathologica Communications. 6(1). 37–37. 40 indexed citations

Koo, Chuay-Yeng, Caterina Giacomini, Yolanda Olmos, et al.. (2017). Targeting TAO Kinases Using a New Inhibitor Compound Delays Mitosis and Induces Mitotic Cell Death in Centrosome Amplified Breast Cancer Cells. Molecular Cancer Therapeutics. 16(11). 2410–2421. 40 indexed citations

Wang, Chunming, Sadasivam Murali, Chuay-Yeng Koo, et al.. (2014). Engineering a vascular endothelial growth factor 165-binding heparan sulfate for vascular therapy. Biomaterials. 35(25). 6776–6786. 53 indexed citations

Xu, Yang, et al.. (2013). SILAC-based phosphoproteomics reveals an inhibitory role of KSR1 in p53 transcriptional activity via modulation of DBC1. British Journal of Cancer. 109(10). 2675–2684. 14 indexed citations

Lam, Eric W.‐F., Jan J. Brosens, Ana Gomes, & Chuay-Yeng Koo. (2013). Forkhead box proteins: tuning forks for transcriptional harmony. Nature reviews. Cancer. 13(7). 482–495. 555 indexed citations breakdown →

Khongkow, Mattaka, Yolanda Olmos, Chun Gong, et al.. (2013). SIRT6 modulates paclitaxel and epirubicin resistance and survival in breast cancer. Carcinogenesis. 34(7). 1476–1486. 129 indexed citations

Zhang, Hua, Chuay-Yeng Koo, Justin Stebbing, & Georgios Giamas. (2013). The dual function of KSR1: a pseudokinase and beyond. Biochemical Society Transactions. 41(4). 1078–1082. 34 indexed citations

10.

Olano, Natalia de, Chuay-Yeng Koo, Lara J. Monteiro, et al.. (2012). The p38 MAPK–MK2 Axis Regulates E2F1 and FOXM1 Expression after Epirubicin Treatment. Molecular Cancer Research. 10(9). 1189–1202. 47 indexed citations

11.

Monteiro, Lara J., Pasarat Khongkow, Mesayamas Kongsema, et al.. (2012). The Forkhead Box M1 protein regulates BRIP1 expression and DNA damage repair in epirubicin treatment. Oncogene. 32(39). 4634–4645. 80 indexed citations

12.

Ibrahim, Sherif, George W. Yip, Christian Stock, et al.. (2012). Targeting of syndecan‐1 by microRNA miR‐10b promotes breast cancer cell motility and invasiveness via a Rho‐GTPase‐ and E‐cadherin‐dependent mechanism. International Journal of Cancer. 131(6). E884–96. 133 indexed citations

13.

Ho, Ka-Kei, Victoria A. McGuire, Chuay-Yeng Koo, et al.. (2011). Phosphorylation of FOXO3a on Ser-7 by p38 Promotes Its Nuclear Localization in Response to Doxorubicin. Journal of Biological Chemistry. 287(2). 1545–1555. 117 indexed citations

14.

Koo, Chuay-Yeng, Kyle Muir, & Eric W.‐F. Lam. (2011). FOXM1: From cancer initiation to progression and treatment. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1819(1). 28–37. 330 indexed citations

15.

Koo, Chuay-Yeng, et al.. (2010). Differential Expression of Metallothionein in Gastrointestinal Stromal Tumors and Gastric Carcinomas. The Anatomical Record. 294(2). 267–272. 13 indexed citations

16.

Götte, Martin, Chuay-Yeng Koo, Christian Stock, et al.. (2010). miR-145-dependent targeting of Junctional Adhesion Molecule A and modulation of fascin expression are associated with reduced breast cancer cell motility and invasiveness. Oncogene. 29(50). 6569–6580. 179 indexed citations

17.

Nikolova, Viktoriya D., Chuay-Yeng Koo, Sherif Ibrahim, et al.. (2009). Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression. Carcinogenesis. 30(3). 397–407. 157 indexed citations

18.

Koo, Chuay-Yeng, et al.. (2008). Targeting Heparan Sulfate Proteoglycans in Breast Cancer Treatment. Recent Patents on Anti-Cancer Drug Discovery. 3(3). 151–158. 22 indexed citations

19.

Koo, Chuay-Yeng, Boon‐Huat Bay, Philip C.W. Lui, et al.. (2006). Immunohistochemical expression of heparan sulfate correlates with stromal cell proliferation in breast phyllodes tumors. Modern Pathology. 19(10). 1344–1350. 21 indexed citations

20.

Khan, Asif M., Judice L.Y. Koh, Chuay-Yeng Koo, et al.. (2004). Systematic analysis of snake neurotoxins' functional classification using a data warehousing approach. Bioinformatics. 20(18). 3466–3480. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact